Nuvation Bio Inc. — Director's Dealing 2025

May 23, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2025-05-21

Reporting Person: VERNON W ANTHONY (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-21	Stock Option (Right to Buy)	$2.03	A	292983	Acquired	2035-05-20	Class A Common Stock (292983)	Direct

Footnotes

F1: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.